文献速递胃肠动力与功能性疾病

慢性便秘或便秘型肠易激综合征患者对药物治疗的不满:81例N-of-1前瞻性试验分析

Patient dissatisfaction with medical therapy for chronic constipation or irritable bowel syndrome with constipation: analysis of N-of-1 prospective trials in 81 patients.
PubMed 文献 · Aliment Pharmacol Ther · 2020-02-12

该研究汇总分析81例慢性便秘或便秘型肠易激综合征门诊患者的N-of-1试验,每个周期至少一个月的有效治疗。结果显示43%的患者未达到治疗满意,基线BMI较低和便秘更严重者满意度更差;多因素分析中仅M-PAC-SYM所测便秘严重度变化与治疗满意显著相关(OR=4.3;P<0.001)。

要点

  • 43%的慢性便秘或便秘型肠易激综合征患者对药物治疗不满意。
  • 基线BMI较低及便秘更严重与更差的治疗结局相关。
  • M-PAC-SYM测量的便秘严重度变化可反映治疗满意度。

核心结论

  • 慢性便秘或便秘型肠易激综合征患者对药物治疗的满意常未得到满足。
  • 较低BMI和更严重的便秘与更差的结局相关。
  • M-PAC-SYM的变化反映治疗满意度。

研究设计与样本

  • 对81例慢性便秘或便秘型肠易激综合征门诊患者的N-of-1试验进行汇总分析。
  • 每个N-of-1试验包含至少一个月的有效治疗周期。
  • 评估了排便协调障碍、肛门静息压、结肠传输时间和躯体化。
  • 采用PAC-SYM问卷及其改良版M-PAC-SYM测量便秘严重度,并每日记录排便用力、大便频率和性状。
  • 统计分析采用 agreement 的K统计量和logistic回归。

主要发现

  • 43%的患者未达到治疗满意。
  • 未达到治疗满意的患者基线BMI显著更低、便秘更严重。
  • 多因素分析中仅M-PAC-SYM所测便秘严重度变化与治疗满意显著相关(OR=4.3;P<0.001)。

关键数值与推荐

  • 治疗满意采用三个主要终点定义:对治疗满意、治疗后改善、以及包含两者的扩展满意标准。
  • M-PAC-SYM变化与治疗满意的关联OR=4.3;P<0.001。
  • 试验注册号ClinicalTrials.gov NCT02813616。

临床怎么用

  • 对慢性便秘或便秘型肠易激综合征患者应关注治疗满意度这一未满足需求。
  • 基线BMI较低、便秘更严重的患者可能需要更积极的评估与干预。
  • 可用M-PAC-SYM追踪便秘严重度变化以反映治疗满意度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with chronic constipation (CC) or with irritable bowel syndrome with constipation are often dissatisfied about their medical therapy, but their condition remains poorly defined. AIM: To evaluate the patients' satisfaction rates and which factors predict favourable outcomes through the aggregate analysis of N-of-1 trials. METHODS: Eighty-one outpatients with CC or with irritable bowel syndrome with constipation underwent N-of-1 trials with at least a one-month cycle of effective treatment. Three primary endpoints (satisfaction with therapy, improvement after treatment and an extended satisfaction criterion including both endpoints) were adopted to define satisfaction with therapy. Dyssynergia, resting anal pressure, colonic transit time and somatisation were assessed. The Patient Assessment of Constipation-Symptoms (PAC-SYM) questionnaire and its Modified version (M-PAC-SYM) measured constipation severity. Straining at defecation, stool frequency and form were daily recorded. K statistics for agreement and logistic regression were used at statistical analysis. RESULTS: Satisfaction with therapy was not achieved by 43% of patients, who had a significantly lower Body Mass Index (BMI) and more severe constipation at baseline. Only the change in constipation severity according to M-PAC-SYM remained significantly associated with satisfaction with therapy (OR = 4.3; P < 0.001) at multivariate analysis. CONCLUSIONS: Satisfaction with therapy is often an unmet need for patients with CC or with irritable bowel syndrome with constipation. Lower BMI and more severe constipation are associated with worse outcome. Changes in M-PAC-SYM reflect satisfaction with therapy. ClinicalTrials.gov no. NCT02813616.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Basilisco G. Patient dissatisfaction with medical therapy for chronic constipation or irritable bowel syndrome with constipation: analysis of N-of-1 prospective trials in 81 patients. Aliment Pharmacol Ther. 2020. PMID: 32048753. doi:10.1111/apt.15657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。